Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Quarterly results
|
|
Flexion Therapeutics Inc (FLXN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/29/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/23/2021 |
4
| Newtyn Management, LLC (10% Owner) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Unknown transaction of 5,900,000 shares
@ $0 |
|
| 11/23/2021 |
3
| Newtyn Management, LLC (10% Owner) has filed a Form 3 on Flexion Therapeutics Inc |
| 11/19/2021 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 12,631 shares
@ $8.5, valued at
$107.4k
Disposed/sold 25,000 options to buy
@ $15.87, valued at
$396.8k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 12,500 options to buy
@ $28.14, valued at
$351.8k
Disposed/sold 12,500 options to buy
@ $11.74, valued at
$146.8k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 11/19/2021 |
4
| MILINAZZO ALAN (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 27,450 shares
@ $8.5, valued at
$233.3k
Disposed/sold 9,000 options to buy
@ $17.61, valued at
$158.5k
Disposed/sold 9,000 options to buy
@ $21.85, valued at
$196.7k
Disposed/sold 12,500 options to buy
@ $13.83, valued at
$172.9k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 12,500 options to buy
@ $28.14, valued at
$351.8k
Disposed/sold 12,500 options to buy
@ $11.74, valued at
$146.8k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 11/19/2021 |
4
| MERRIFIELD C ANN (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 19,000 shares
@ $8.5, valued at
$161.5k
Disposed/sold 18,000 options to buy
@ $12.72, valued at
$229k
Disposed/sold 9,000 options to buy
@ $21.85, valued at
$196.7k
Disposed/sold 12,500 options to buy
@ $13.83, valued at
$172.9k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 12,500 options to buy
@ $28.14, valued at
$351.8k
Disposed/sold 12,500 options to buy
@ $11.74, valued at
$146.8k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 11/19/2021 |
4
| Lukatch Heath (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 9,000 shares
@ $8.5, valued at
$76.5k
Disposed/sold 9,000 options to buy
@ $21.85, valued at
$196.7k
Disposed/sold 12,500 options to buy
@ $13.83, valued at
$172.9k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 11/19/2021 |
4
| Kwo Elizabeth (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 4,500 shares
@ $8.5, valued at
$38.3k
Disposed/sold 32,000 options to buy
@ $12.54, valued at
$401.3k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 11/19/2021 |
4
| Koppikar Utpal (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 32,000 options to buy
@ $7.82, valued at
$250.2k
|
|
| 11/19/2021 |
4
| COLELLA SAMUEL D (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 9,000 shares
@ $8.5, valued at
$76.5k
Disposed/sold 1,000 shares
@ $8.5, valued at
$8.5k
Disposed/sold 72,035 shares
@ $8.5, valued at
$612.3k
Disposed/sold 5,000 shares
@ $8.5, valued at
$42.5k
Disposed/sold 994,129 shares
@ $8.5, valued at
$8.5M
Disposed/sold 5,871 shares
@ $8.5, valued at
$49.9k
Disposed/sold 388,683 shares
@ $8.5, valued at
$3.3M
Disposed/sold 943 shares
@ $8.5, valued at
$8k
Disposed/sold 19,653 shares
@ $8.5, valued at
$167.1k
Disposed/sold 250 shares
@ $8.5, valued at
$2.1k
Disposed/sold 9,000 options to buy
@ $17.61, valued at
$158.5k
|
|
| 11/19/2021 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 9,000 shares
@ $8.5, valued at
$76.5k
Disposed/sold 18,000 options to buy
@ $25.38, valued at
$456.8k
Disposed/sold 9,000 options to buy
@ $21.85, valued at
$196.7k
Disposed/sold 12,500 options to buy
@ $13.83, valued at
$172.9k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 12,500 options to buy
@ $28.14, valued at
$351.8k
Disposed/sold 12,500 options to buy
@ $11.74, valued at
$146.8k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 11/19/2021 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 39,824 shares
@ $8.5, valued at
$338.5k
Disposed/sold 18,000 options to buy
@ $17.61, valued at
$317k
Disposed/sold 18,000 options to buy
@ $21.85, valued at
$393.3k
Disposed/sold 18,000 options to buy
@ $13.83, valued at
$248.9k
Disposed/sold 18,000 options to buy
@ $20.16, valued at
$362.9k
Disposed/sold 18,000 options to buy
@ $28.14, valued at
$506.5k
Disposed/sold 18,000 options to buy
@ $11.74, valued at
$211.3k
Disposed/sold 12,500 options to buy
@ $11.88, valued at
$148.5k
Disposed/sold 12,500 options to buy
@ $9.22, valued at
$115.3k
|
|
| 11/19/2021 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 133,486 shares
@ $8.5, valued at
$1.1M
Disposed/sold 125,000 options to buy
@ $21.74, valued at
$2.7M
Disposed/sold 33,333 options to buy
@ $22.31, valued at
$743.7k
Disposed/sold 18,000 options to buy
@ $14.75, valued at
$265.5k
Disposed/sold 15,500 options to buy
@ $15.78, valued at
$244.6k
Disposed/sold 20,000 options to buy
@ $11.41, valued at
$228.2k
|
|
| 11/19/2021 |
4
| Muzikant Adam (Chief Business Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 103,666 shares
@ $8.5, valued at
$881.2k
Disposed/sold 40,000 options to buy
@ $16.35, valued at
$654k
Disposed/sold 25,000 options to buy
@ $18.56, valued at
$464k
Disposed/sold 16,667 options to buy
@ $22.31, valued at
$371.8k
Disposed/sold 11,000 options to buy
@ $14.75, valued at
$162.3k
Disposed/sold 20,000 options to buy
@ $11.41, valued at
$228.2k
|
|
| 11/19/2021 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 140,843 shares
@ $8.5, valued at
$1.2M
Disposed/sold 6,000 shares
@ $8.5, valued at
$51k
Disposed/sold 24,000 options to buy
@ $19.61, valued at
$470.6k
Disposed/sold 10,000 options to buy
@ $22.91, valued at
$229.1k
Disposed/sold 10,000 options to buy
@ $18.16, valued at
$181.6k
Disposed/sold 20,000 options to buy
@ $18.2, valued at
$364k
Disposed/sold 35,000 options to buy
@ $18.56, valued at
$649.6k
Disposed/sold 33,333 options to buy
@ $22.31, valued at
$743.7k
Disposed/sold 18,000 options to buy
@ $14.75, valued at
$265.5k
Disposed/sold 15,500 options to buy
@ $15.78, valued at
$244.6k
Disposed/sold 20,000 options to buy
@ $11.41, valued at
$228.2k
|
|
| 11/19/2021 |
4
| Layman Melissa (Chief Commercial Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 103,956 shares
@ $8.5, valued at
$883.6k
Disposed/sold 30,000 options to buy
@ $7.01, valued at
$210.3k
Disposed/sold 20,100 options to buy
@ $0 |
|
| 11/19/2021 |
4
| Willwerth Christina (Chief Strategy Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 141,241 shares
@ $8.5, valued at
$1.2M
Disposed/sold 25,830 options to buy
@ $2.52, valued at
$65.1k
Disposed/sold 32,000 options to buy
@ $17.61, valued at
$563.5k
Disposed/sold 25,000 options to buy
@ $22.91, valued at
$572.8k
Disposed/sold 5,000 options to buy
@ $29.06, valued at
$145.3k
Disposed/sold 20,000 options to buy
@ $18.2, valued at
$364k
Disposed/sold 25,000 options to buy
@ $18.56, valued at
$464k
Disposed/sold 23,333 options to buy
@ $22.31, valued at
$520.6k
Disposed/sold 18,000 options to buy
@ $14.75, valued at
$265.5k
Disposed/sold 15,500 options to buy
@ $15.78, valued at
$244.6k
Disposed/sold 20,000 options to buy
@ $11.41, valued at
$228.2k
|
|
| 11/19/2021 |
4
| DRISCOLL FREDERICK W (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 30,680 shares
@ $8.5, valued at
$260.8k
Disposed/sold 168,000 options to buy
@ $8.35, valued at
$1.4M
|
|
| 11/19/2021 |
4
| Andrews William T. (Chief Medical Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 34,250 shares
@ $8.5, valued at
$291.1k
Disposed/sold 205,500 options to buy
@ $6.25, valued at
$1.3M
|
|
| 11/19/2021 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 335,498 shares
@ $8.5, valued at
$2.9M
Disposed/sold 373,769 shares
@ $8.5, valued at
$3.2M
Disposed/sold 24,600 shares
@ $8.5, valued at
$209.1k
Disposed/sold 388,683 shares
@ $8.5, valued at
$3.3M
Disposed/sold 136,530 options to buy
@ $2.52, valued at
$344.1k
Disposed/sold 200,000 options to buy
@ $17.61, valued at
$3.5M
Disposed/sold 110,000 options to buy
@ $22.91, valued at
$2.5M
Disposed/sold 155,000 options to buy
@ $18.2, valued at
$2.8M
Disposed/sold 175,000 options to buy
@ $18.56, valued at
$3.2M
Disposed/sold 116,667 options to buy
@ $22.31, valued at
$2.6M
Disposed/sold 290,000 options to buy
@ $14.75, valued at
$4.3M
|
|
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/19/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/19/2021 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...|
Docs:
|
"AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF FLEXION THERAPEUTICS, INC.",
"BYLAWS OF FLEXION THERAPEUTICS, INC.",
"Supplemental Indenture”), between Flexion Therapeutics, Inc., a Delaware corporation , as issuer, and Wells Fargo Bank, National Association, a national banking association organized under the laws of the United States of America, as trustee , to the Indenture, dated as of May 2, 2017 (as supplemented or otherwise modified prior to the date hereof, the “Indenture" |
|
| 11/19/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/19/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|